X-136207911-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001159699.2(FHL1):c.499G>A(p.Val167Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000027 ( 0 hom. 3 hem. )
Failed GnomAD Quality Control
Consequence
FHL1
NM_001159699.2 missense
NM_001159699.2 missense
Scores
9
8
Clinical Significance
Conservation
PhyloP100: 3.19
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL1 | NM_001159702.3 | c.451G>A | p.Val151Met | missense_variant | 5/8 | ENST00000394155.8 | NP_001153174.1 | |
FHL1 | NM_001159699.2 | c.499G>A | p.Val167Met | missense_variant | 4/6 | ENST00000370683.6 | NP_001153171.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000394155.8 | c.451G>A | p.Val151Met | missense_variant | 5/8 | 5 | NM_001159702.3 | ENSP00000377710.2 | ||
FHL1 | ENST00000370683.6 | c.499G>A | p.Val167Met | missense_variant | 4/6 | 1 | NM_001159699.2 | ENSP00000359717.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183408Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67854
GnomAD3 exomes
AF:
AC:
1
AN:
183408
Hom.:
AF XY:
AC XY:
1
AN XY:
67854
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000273 AC: 3AN: 1098190Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 3AN XY: 363544
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
3
AN:
1098190
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
363544
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
X-linked myopathy with postural muscle atrophy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 548468). This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with methionine at codon 151 of the FHL1 protein (p.Val151Met). The valine residue is moderately conserved and there is a small physicochemical difference between valine and methionine. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Mar 05, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.;T;.;T;T;.;T;.;T;.;.;T;.;T;.;.;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.;D;D;D;D;.;.;.;D;.;D;D;D;.;D;D;D;D;.
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L;L;.;L;.;.;L;.;L;.;L;L;.;.;L;.;.;.;.;L
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;.;.;N;N;.;N;N;N;N;N;N;.;N;N;N;N;N;.
REVEL
Uncertain
Sift
Uncertain
.;D;D;.;.;D;D;.;D;D;D;D;D;D;.;D;D;D;D;D;.
Sift4G
Benign
T;T;T;D;T;D;T;T;T;T;T;T;T;D;T;T;T;T;T;T;T
Polyphen
0.67, 0.44
.;P;.;.;.;.;.;.;.;.;.;.;.;.;.;P;.;.;B;.;.
Vest4
MutPred
Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);.;.;.;Gain of catalytic residue at V151 (P = 0.0636);Gain of catalytic residue at V151 (P = 0.0636);
MVP
MPC
1.0
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at